Concepedia

Grigory Volchenkov

GV

16

Publications

1.1K

Citations

13

H-Index

2009

Active since

Affiliations

Centers for Disease Control and Prevention(Current)

South African Medical Research Council

National Institute of Quality

Central Scientific Research Institute of Tuberculosis Russian Academy of Medical Sciences

Tropical Disease Foundation

Grigory Volchenkov is an author at Centers for Disease Control and Prevention specializing in drug resistance, tuberculosis, and antimicrobial resistance.

ORCID

Top concepts

Publications per year

2009–2021

16

Publications

16

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Tracy Dalton, Peter Cegielski, Somsak Akksilp et al. · The Lancet · 2012 · 224 citations · Full text

, , +12

Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies

Ekaterina V. Kurbatova, J. Peter Cegielski, Christian Lienhardt et al. · The Lancet Respiratory Medicine · 2015 · 156 citations · Full text

, , +8

Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study

Aditya Sharma, Andrew Hill, Ekaterina V. Kurbatova et al. · The Lancet Infectious Diseases · 2017 · 151 citations · Full text

Extensive Drug Resistance Acquired During Treatment of Multidrug-Resistant Tuberculosis

J. Peter Cegielski, Tracy Dalton, Martín Yagui et al. · Clinical Infectious Diseases · 2014 · 149 citations · Full text

Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance

J. Peter Cegielski, Ekaterina V. Kurbatova, Martie van der Walt et al. · Clinical Infectious Diseases · 2015 · 100 citations · Full text

Rows per page

1–5 of 16